Letrozole 2.5 mg Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Letrozole 2.5 mg Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Non-Steroidal Aromatase Inhibitor
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Letrozole 2.5 mg Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Letrozole 2.5 mg Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Letrozole 2.5 mg Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Letrozole 2.5 mg formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Adjuvant therapy of HR+ breast cancer (post-menopausal)
- Metastatic HR+ breast cancer
- Ovulation induction in PCOS (off-label)
- Endometrial cancer (selected cases)
- Endometriosis (selected cases)
Mechanism of Action
Letrozole is a third-generation non-steroidal aromatase inhibitor — reversibly blocks the enzyme aromatase (CYP19A1) which converts androgens to oestrogens. Reduces circulating oestradiol by >98% in post-menopausal women. Also used in PCOS for ovulation induction (off-label, evidence-supported).
Dosage & Administration
- Breast cancer: 2.5 mg once daily continuously.
- Ovulation induction: 2.5–7.5 mg days 3–7 of cycle.
Side Effects
- Hot flushes, arthralgia, fatigue, headache, bone loss (long-term — monitor BMD), hypercholesterolaemia.
Contraindications
- Pre-menopausal women (without ovarian suppression), pregnancy, lactation, severe hepatic impairment, hypersensitivity.
Storage
Store below 30 °C in a dry place, protected from light and moisture.
PCD Pharma Franchise for Letrozole 2.5 mg Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 20 x 5 (Blister)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Letrozole 2.5 mg Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Letrozole 2.5 mg Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Letrozole 2.5 mg Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Letrozole 2.5 mg Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Letrozole 2.5 mg Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Letrozole 2.5 mg Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Letrozole 2.5 mg Tablet?
Available pack sizes include: 20 x 5 (Blister).
What is the MRP / trade price for Letrozole 2.5 mg Tablet?
MRPs range from ₹1900 to ₹1900 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Letrozole 2.5 mg Tablet?